Bayer Plans Continued Growth in Japan

Related Vendors

Gerhard Schubert GmbH - Verpackungsmaschinen

Italvacuum, Srl

Angst+Pfister AG

Bayer AG

Bayer`s Business in Japan

Pharmaceuticals account for the largest share of Bayer's business in Japan, where the company currently has 28 products in Phase II or III clinical studies. Bayer has also submitted applications to the Japanese Ministry of Health, Labor and Welfare for marketing approval for Xarelto (rivaroxaban) in the prevention of stroke in patients with atrial fibrillation and for VEGF Trap-Eye for the treatment of wet age-related macular degeneration (AMD).

In the crop protection business, too, Bayer expects positive development in Japan from new products such as the herbicide InnovaTrio, which was launched in March. It also has two insecticide-fungicide combination products under development that are effective in rice and are scheduled for market introduction before the end of this year.

Business of the MaterialScience subgroup in Japan is also developing favorably in view of rising demand for high-performance construction and insulating materials, especially following the earthquake, and the resumption of growth in automotive production.

(ID:29573220)